
Pharma Business - March 30, 2015
Karolinska Sells Axelar Shares
Karolinska Development AB has sold its shares in Axelar AB to The Foundation for Baltic and East European Studies (Östersjöstiftelsen). The agreement is in keeping with Karolinska Development’s current strategy. “Karolinska Development’s new strategy includes focusing on our strategic portfolio, an increased emphasis on leadership within our portfolio companies, proactively syndicating our investments with […]

In a new job - February 3, 2015
Karolinska Dev. CEO Out
Karolinska Development AB’s CEO Bruno Lucidi is leaving the company, according to a company announcement. He is being replaced by Development Deputy CEO Terje Kalland until a permanent CEO is named. The search for a permanent replacement already has begun. “The Board of Directors recognizes that the Board and Bruno Lucidi are of different opinions […]